Safety of SGLT2 inhibitors, DPP-4 inhibitors, and GLP-1 receptor agonists in US veterans with and without chronic kidney disease: a population-based study
Titel:
Safety of SGLT2 inhibitors, DPP-4 inhibitors, and GLP-1 receptor agonists in US veterans with and without chronic kidney disease: a population-based study
Auteur:
Narasaki, Yoko Kovesdy, Csaba P. You, Amy S. Sumida, Keiichi Mallisetty, Yamini Surbhi, Satya Thomas, Fridtjof Amin, Alpesh N. Streja, Elani Kalantar-Zadeh, Kamyar Rhee, Connie M.